Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM
Recruiting
N/A
Interventional Study
Type 2 Diabetes Mellitus
Obesity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 160 (estimated)
- Sponsor
- Universiti Putra Malaysia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Globally, chronic noncommunicable diseases rank as the leading cause of morbidity and mortality. Diabetes is reaching high epidemic proportions across the globe. The prevalence of diabetes is increasing in Saudi Arabia, with diabetes affecting 14.1% of the population across all age groups and 28% of those over the age of 30. Date seed intake is one of the best-studied patterns. Previous studies fi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged 18 years old and above.
* Diagnosis of Type 2 diabetes.
* Receiving and monitoring diabetes care from diabetes center.
* With stable HbA1c less than 10% (no episode of hypoglycaemia, no hospitalisation, no change in type or dosage of medication use for at least 6 months).…
Contacts